Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00196534Phase 3Completed
Phase 3, randomised, double-blind trial of thrombin (2 arms), sponsored by Ethicon. Primary endpoint: Success in achieving hemostasis at 10 minutes. Started Nov 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00196534.